Atoxifent
Appearance
| Clinical data | |
|---|---|
| Drug class | painkiller; opioid |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C21H26N2O |
| Molar mass | 322.452 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Atoxifent It is an extremely potent opioid; its pain-relieving effect is comparable to that of fentanyl, and atoxifent, even at doses that induce complete analgesia, does not cause severe respiratory depression.[1][2]
Pharmacology
[edit]Pharmacodynamics
[edit]Atoxifent is an agonist of the μ-opioid and δ-opioid receptors. its EC50 value for MOR is 0.39 ± 0.03 nM, with an efficacy (Emax) of 98.9 ± 0.6 per cent. Atoxifent is a partial agonist of δ-opioid receptors with an EC50 value of 2.18 ± 0.50 nM and an Emax of 56.8 ± 11.0% it is a full κ-opioid receptor antagonist with an EC50 value of 356.50 ± 106.49 nM and an Emax of 93.0 ± 2.0 per cent. It showed no affinity for nociceptin receptors.[1][2]
References
[edit]- 1 2 Vu LY, Luo D, Johnson K, Denehy ED, Songrady JC, Martin J, et al. (June 2024). "Searching for Synthetic Opioid Rescue Agents: Identification of a Potent Opioid Agonist with Reduced Respiratory Depression". Journal of Medicinal Chemistry. 67 (11): 9173–9193. doi:10.1021/acs.jmedchem.4c00333. PMC 12054644. PMID 38810170.
- 1 2 Trivedi RR, Luo D, Hessing MC, Prantzalos E, Alilain WJ, Turner JR, et al. (November 2025). "N-(3-Hydroxyphenyl)-3,8-diazabicyclooctanes as opioid receptors probes. 1. Investigation of the phenolic hydroxyl group". European Journal of Medicinal Chemistry. 298 117991. doi:10.1016/j.ejmech.2025.117991. PMC 12374581. PMID 40730064.